Merck Manual

Please confirm that you are a health care professional

Loading

Hartnup Disease

(Hartnup's Disease)

By

Christopher J. LaRosa

, MD, Perelman School of Medicine at The University of Pennsylvania

Last full review/revision Jan 2020| Content last modified Jan 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Hartnup disease is a rare autosomal recessive disease involving malabsorption and increased renal excretion of tryptophan and other amino acids. Also, conversion of tryptophan to niacinamide is impaired. Symptoms are rash, central nervous system abnormalities, short stature, headache, and collapsing or fainting. Diagnosis is by high urinary content of tryptophan and other amino acids. Prevention is with niacinamide or niacin, and attacks are treated with nicotinamide.

Hartnup disease is caused by a mutation in the sodium-dependent neutral amino acid transporter gene (SLC6A19) that is expressed in kidney and intestinal epithelia. It is inherited as an autosomal recessive trait.

Small-bowel malabsorption of tryptophan, phenylalanine, methionine, and other monoaminomonocarboxylic amino acids occurs. Accumulation of unabsorbed amino acids in the gastrointestinal tract increases their metabolism by bacterial flora. Some tryptophan degradation products, including indoles, kynurenine, and serotonin, are absorbed by the intestine and appear in the urine. Renal amino acid resorption is also defective, causing a generalized aminoaciduria involving all neutral amino acids except proline and hydroxyproline. Conversion of tryptophan to niacinamide is also defective.

Symptoms and Signs

Although the disorder is present from birth, symptoms of Hartnup disease may manifest in infancy, childhood, or early adulthood. Symptoms may be precipitated by sunlight, fever, drugs, or other stresses.

Poor nutritional intake nearly always precedes appearance of symptoms. Symptoms and signs are due to niacinamide deficiency and resemble those of pellagra, particularly the rash on parts of the body exposed to the sun; mucous membrane and neurologic symptoms also occur. Neurologic manifestations include cerebellar ataxia and mental abnormalities. Intellectual disability, short stature, headache, and collapsing or fainting are common. Psychiatric symptoms also occur, including emotional lability and psychosis.

Diagnosis

  • Urine testing for amino acids

Diagnosis of Hartnup disease is made by showing the characteristic amino acid excretion pattern in the urine. Indoles and other tryptophan degradation products in the urine provide supplementary evidence of the disease.

Treatment

  • Niacin or niacinamide supplements

  • Nicotinamide for attacks

The number and severity of attacks can be reduced by maintaining good nutrition and supplementing the diet with oral niacin or niacinamide 50 to 100 mg 2 times a day.

Attacks may be treated with oral nicotinamide 20 mg once a day.

Prognosis is good, and frequency of attacks usually diminishes with age.

Drugs Mentioned In This Article

Drug Name Select Trade
No US brand name
NIACOR, NIASPAN
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Ventricular Septal Defect
Video
Overview of Ventricular Septal Defect
3D Models
View All
Cystic Fibrosis: Defective Chloride Transport
3D Model
Cystic Fibrosis: Defective Chloride Transport

SOCIAL MEDIA

TOP